Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,207 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of subcutaneous tumor with adoptively transferred T cells.
Peng L, Shu S, Krauss JC. Peng L, et al. Cell Immunol. 1997 May 25;178(1):24-32. doi: 10.1006/cimm.1997.1124. Cell Immunol. 1997. PMID: 9184695
Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.
Kjaergaard J, Peng L, Cohen PA, Drazba JA, Weinberg AD, Shu S. Kjaergaard J, et al. Among authors: peng l. J Immunol. 2001 Dec 1;167(11):6669-77. doi: 10.4049/jimmunol.167.11.6669. J Immunol. 2001. PMID: 11714839
Advanced 10-day 3-methylcholanthrene 205 intracranial tumors could be cured by the transfer of 15 x 10(6) L-selectin(low) T cells derived from draining lymph nodes. ...
Advanced 10-day 3-methylcholanthrene 205 intracranial tumors could be cured by the transfer of 15 x 10(6) L-selectin(low) T cells der …
T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA, Peng L, Kjaergaard J, Plautz GE, Finke JH, Koski GK, Czerniecki BJ, Shu S. Cohen PA, et al. Among authors: peng l. Crit Rev Immunol. 2001;21(1-3):215-48. Crit Rev Immunol. 2001. PMID: 11642606 Review.
In mouse studies, the L-selectin(low) fraction of T cells in tumor-draining lymph nodes (TDLN) constitutes the potent pre-effector population and comprises both CD4+ and helper-independent CD8+ T cells. ...Given the increasingly appreciated and critical communications betw …
In mouse studies, the L-selectin(low) fraction of T cells in tumor-draining lymph nodes (TDLN) constitutes the potent pre-effector po …
T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics.
Peng L, Krauss JC, Plautz GE, Mukai S, Shu S, Cohen PA. Peng L, et al. J Immunol. 2000 Dec 15;165(12):7116-24. doi: 10.4049/jimmunol.165.12.7116. J Immunol. 2000. PMID: 11120842
Helper-independent, L-selectinlow CD8+ T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression.
Peng L, Kjaergaard J, Plautz GE, Weng DE, Shu S, Cohen PA. Peng L, et al. J Immunol. 2000 Nov 15;165(10):5738-49. doi: 10.4049/jimmunol.165.10.5738. J Immunol. 2000. PMID: 11067932
Isolated L-selectin(low) CD8(+) T cells displayed the functional phenotype of helper-independent T cells, and when adoptively transferred could consistently eradicate, like L-selectin(low) CD4(+) T cells, both established pulmonary and intracranial tumors without co …
Isolated L-selectin(low) CD8(+) T cells displayed the functional phenotype of helper-independent T cells, and when adoptively transfe …
CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.
Cohen PA, Peng L, Plautz GE, Kim JA, Weng DE, Shu S. Cohen PA, et al. Among authors: peng l. Crit Rev Immunol. 2000;20(1):17-56. Crit Rev Immunol. 2000. PMID: 10770269 Review.
Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation.
Zeng W, Shen J, Bo T, Peng L, Xu H, Nasser MI, Zhuang Q, Zhao M. Zeng W, et al. Among authors: peng l. J Immunol Res. 2019 Apr 16;2019:1603758. doi: 10.1155/2019/1603758. eCollection 2019. J Immunol Res. 2019. PMID: 31143780 Free PMC article. Review.
Post-Acute Care as a Key Component in a Healthcare System for Older Adults.
Wang YC, Chou MY, Liang CK, Peng LN, Chen LK, Loh CH. Wang YC, et al. Among authors: peng ln. Ann Geriatr Med Res. 2019 Jun;23(2):54-62. doi: 10.4235/agmr.19.0009. Epub 2019 Jun 30. Ann Geriatr Med Res. 2019. PMID: 32743289 Free PMC article. Review.
5,207 results
Jump to page
Feedback